Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Sep 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4591208015 | Mesenchymal epithelial transition inhibitor | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4591210018 | Mesenchymal epithelial transition inhibitor (disposition) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 4591211019 | MET (mesenchymal epithelial transition) inhibitor | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mesenchymal epithelial transition inhibitor | Is a | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Substance with mesenchymal epithelial transition inhibitor mechanism of action (substance) | Has disposition | True | Mesenchymal epithelial transition inhibitor | Inferred relationship | Existential restriction modifier | |
| Amivantamab | Has disposition | True | Mesenchymal epithelial transition inhibitor | Inferred relationship | Existential restriction modifier | |
| Capmatinib | Has disposition | True | Mesenchymal epithelial transition inhibitor | Inferred relationship | Existential restriction modifier | |
| Tepotinib | Has disposition | True | Mesenchymal epithelial transition inhibitor | Inferred relationship | Existential restriction modifier | |
| Tepotinib hydrochloride | Has disposition | True | Mesenchymal epithelial transition inhibitor | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR